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actin moving assay on a microtubule bridge (21) , a modification of the actin-bridge assay (15) , by suspending a microtubule between two large beads immobilized on a glass surface to let the actin filament freely rotate in any direction. We found three swinging actin filaments that stayed primarily in the image plane and that were simultaneously translocated. All showed asymmetric swings (Fig. 4, fig. S6 , and movies S5 and S6). When these filaments fluctuated, we saw moments when the filament became perpendicular to the image plane, appearing as a bright dot (red dotted frames in Fig. 4B ; also Fig. 1C ). Apparently the free neck could assume all orientations in space.
By attaching a micrometer-sized rod to a neck of the nanometer-sized molecular motor, we have been able to infer the neck motion continuously in real time. Viscous friction on the rod must slow down the motion, but essential features are likely preserved, as shown for the rotation of F 1 -ATPase (29) . The two necks of myosin Vare connected via a free joint. Thus, the sole mechanism that can move a lifted head is Brownian rotation of the neck, but this is purely random, carrying the head in either direction with an equal probability. Ensuring forward landing thus requires a biasing mechanism(s). ATP-powered lever action of the landed neck, originally proposed for myosin II (30) , moves forward the pivot of the Brownian rotation, producing the required bias, as has been suggested in electron microscopy and singlemolecule studies (16, 19, 26, 27) . The rotational diffusion observed here implies that the lifted head stays off the actin surface for most of the time, as opposed to diffusional sliding of the myosin head along the actin surface (31) . The rotational diffusion plus lever action, however, may not be sufficient. We have proposed that, to ensure forward landing of a lifted head in the presence of backward load, the track-binding surface of the head must be properly oriented such that forward swing of the neck makes the surface parallel with the track surface (24, 25, 32) . One way to prove this orientational biasing experimentally is to attach a micrometer-sized rod. A rod that directly reports molecular orientations will be useful in studies where a conformational change in a protein machine, necessarily accompanying reorientation, is to be visualized during function. The roles of endocannabinoid signaling during central nervous system development are unknown. We report that CB 1 cannabinoid receptors (CB 1 Rs) are enriched in the axonal growth cones of g-aminobutyric acid-containing (GABAergic) interneurons in the rodent cortex during late gestation. Endocannabinoids trigger CB 1 R internalization and elimination from filopodia and induce chemorepulsion and collapse of axonal growth cones of these GABAergic interneurons by activating RhoA. Similarly, endocannabinoids diminish the galvanotropism of Xenopus laevis spinal neurons. These findings, together with the impaired target selection of cortical GABAergic interneurons lacking CB 1 Rs, identify endocannabinoids as axon guidance cues and demonstrate that endocannabinoid signaling regulates synaptogenesis and target selection in vivo.
I n the cerebral cortex, information processing requires the precise temporal and spatial coordination of synaptic communication among excitatory pyramidal cells, inhibitory g-aminobutyric acid-containing (GABAergic) interneurons, and subcortical afferents (1) . Cortical neurons are born in progenitor zones that are distant from their final positions, and their layer-specific patterning is achieved through extensive migration in the developing cerebrum (1, 2) . En route to their destination, cortical neurons establish their synaptic connectivity patterns (3), thus providing the blueprint for their functional diversification.
In the adult central nervous system (CNS), presynaptic G i/o protein-coupled CB 1 cannabinoid receptors (CB 1 Rs) (4) are the targets of marijuana (Cannabis spp.)-derived psychoactive phytocannabinoids and of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Endocannabinoids released from postsynaptic neurons serve as retrograde messengers that suppress neurotransmitter release at mature cortical synapses (4) . During brain development, CB 1 Rs are first expressed in early neural progenitors (5), with receptor levels increasing throughout neuronal specification and synaptogenesis (6) . Although functionally active CB 1 Rs are localized to developing axonal projections (6, 7) , it remains unknown whether endocannabinoids function as diffusible axon guidance factors before the growth cone differentiates into a presynaptic nerve terminal.
We defined the precise cellular distribution of CB 1 Rs on neuronal precursors during cortical cell migration, axonal navigation, and synaptogenesis by high-resolution laser-scanning microscopy of genetically tagged neurons, in situ hybridization, and electron microscopy (3, 8) . From embryonic day 13.5 (E13.5) until birth, CB 1 Rs were present on pyramidal cells (Fig. 1, A to C) with their axons coursing in the intermediate zone of the developing cerebral cortex (9) (Fig. 1, D and E) and establishing the fornix pathway in the hippocampus (figs. S1 and S2). These projections primarily contained CB 1 Rs associated with the surface of distal axon segments, with CB 1 Rs being largely absent from their growth cones (Fig.  1F) . In contrast, CB 1 Rs were expressed in GABAergic interneurons during late gestation as they were undergoing intracortical tangential or radial migration (Fig. 1G) . Here, CB 1 Rs were preferentially found on axons and axonal growth cones ( Fig. 1 , H to J) coincident with establishing target-specific synaptic connectivity patterns (3, 10) .
CB 1 R expression is spatially and temporally coordinated with endocannabinoid synthesis during brain development: sn-1-diacylglycerol lipases a and b (DAGLa/b), which synthesize 2-AG, predominated in elongating long-range telencephalic axons at around E14.5 ( fig. S2 ) (11) . By E18.5, however, DAGLa/b expression was localized to postsynaptic dendrites of glutamatergic pyramidal cells (Fig. 1 , K to N), so that focal 2-AG release could control axonal growth cone steering and the formation of CB 1 R + terminals (Fig.  1O ). Postsynaptic DAGLa expression exceeded that of DAGLb in the perinatal neocortex, in agreement with previous observations establishing DAGLa as the major postnatal DAGL isoform (11) . Unexpectedly, the expression of N-acyl-phosphatidyl-ethanolamine-selective phospholipase D (NAPE-PLD), an enzyme participating in AEA synthesis (4), was delayed until E18.5, at which age NAPE-PLD was strongly associated with cortical pyramidal cells ( Fig. 1 , P and Q). GABAergic interneurons did not possess these endocannabinoid synthetic enzymes until their engagement in radial intracortical migration, coincident with the onset of postsynaptic target selection ( Fig. 1R) (3) .
To identify the functions of endocannabinoid signaling in axonal growth and guidance, we established GABAergic interneuron cultures with high CB 1 R expression (12) . Early growth cones of quiescent axons contained CB 1 Rs localized to their leading filopodial tips ( Fig. 2A) . Morphological growth cone differentiation was associated with a gradual enrichment in CB 1 Rs that were invariably present in motile filopodial tips at the leading edge of the growth cones (Fig. 2 , B and C, and movie S1), which are critical for sensing guidance cues (13) . Application of AEA for 15 to 30 min induced CB 1 R translocation from filopodial tips to the central growth cone domain of GABAergic interneurons (Fig. 2, D and D′) and triggered receptor internalization and retrograde transport in hippo- campal neurons and PC12 pheochromocytoma cells recombinantly expressing CB 1 Rs (fig. S3 ). Agonist-induced activation and trafficking of CB 1 Rs translated into downstream signaling in cultured interneurons, because AEA (100 nM), like brain-derived neurotrophic factor (BDNF) (14) , induced significant phosphorylation of Erk1 and Erk2 (Erk1/2) (15) in the central growth cone domain within 10 min (Fig. 2, E and E′) . Studies in the growth cone particulate fraction isolated from embryonic rat cortices corroborated our in vitro findings by showing significant Erk2 phosphorylation that peaked 5 to 10 min after AEA (2 mM) application (Fig. 2F) . Direct involvement of chemotropic (endo) cannabinoid signaling in growth cone guidance was tested by assaying the growth cone turning responses of GABAergic interneurons induced by the synthetic CB 1 R agonist WIN55,212-2 (16) (17) (18) . A microgradient of BDNF, an established chemoattractive factor for GABAergic interneurons (12), induced attractive turning (16) , whereas WIN55,212-2 at a concentration of 20 mM in the micropipette and~200 nM at the growth cone (16) elicited growth cone repulsion (Fig. 3, A and B, and table S1). In n = 13 out of 20 motile growth cones (65%), WIN55,212-2 induced growth cone collapse and neurite retraction within the 60 min of recording (Fig. 3, A and B, and table S1). The lack of directional growth cone turning or neurite retraction in a control [dimethyl sulfoxide (DMSO)] gradient excluded recording artefacts produced by positive ejection pressure or the vehicle solution itself.
Coapplication of the CB 1 R antagonist AM251 (1 mM simultaneously in the pipette and bath solution) converted WIN55,212-2-induced chemorepulsion to attractive growth cone turning without significantly affecting the rate of neurite extension (Fig. 3B and table S1 ). Together with the lack of detectable CB 2 cannabinoid receptor expression in cultured GABAergic interneurons (12) , these findings indicate that WIN55,212-2-induced chemorepulsion is mediated by CB 1 Rs.
Next, we analyzed whether AEA and WIN55,212-2 modify directional growth cone steering of Xenopus laevis spinal neurons, which also express CB 1 Rs (Fig. 3C) . Growth cones steadily turned toward the cathode of a direct current (DC) electric field (EF) of 150 mV/mm (Fig. 3, D and E) , a gradient that mimics the~400 mV/mm DC-EF present naturally in the developing Xenopus neural tube (19) [supporting online material (SOM) text and fig. S4 ]. Bath application of either AEA or WIN55,212-2, but not its inactive stereoisomer WIN55,212-3, diminished both the mean angle turned toward the cathode and the frequency of cathodal turning in a dose-dependent fashion (Fig. 3 , E and F, and table S1). Reminiscent of the ability of WIN55,212-2 to induce chemorepulsion (Fig. 3A) , AEA or WIN55,212-2, but not WIN55,212-3, increased the frequency of EF-induced cathodal repulsion (anodal attraction) relative to vehicle controls (Fig. 3F) .
Dynamic polarization of the growth cone cytoskeleton underlies chemotropism and galvanotropism: Extending microfilaments predominate on the side of the growth cone nearest to a chemoattractant source, whereas localized collapse of the actin cytoskeleton occurs near a repellent stimulus (18, 19) . Cytoskeletal integrity in axonal growth cones is controlled by members of the Rho family of small guanosine triphosphatases (GTPases) (19, 20) , which act as molecular switches that transduce extracellular stimuli to the actin cytoskeleton (18) . Accordingly, WIN55,212-2 (2 mM) treatment selectively increased the GTP-bound active state of RhoA but not cumulative RhoA, -B, and -C activity (20) in primary cortical cultures after 5 min of stimulation (Fig. 4A) . The involvement of CB 1 Rs in this process was confirmed by the lack of RhoA activation in the presence of AM251 (2 mM; Fig. 4B ). AEA (2 mM) induced RhoA activation in a manner similar to that of WIN55,212-2 (Fig. 4B) . Spatially restricted activation of RhoA in the collapsing growth cone is associated with filopodial retraction and growth cone repulsion in response to chemical and electrical extracellular cues (18, 19) through activation of the serine-threonine kinase Rho kinase (ROCK) and subsequent phosphorylation of myosin light chains (19, 21) (fig. S5 ). Pretreating interneuron cultures with the ROCK-selective inhibitor Y-27632 (50 mM) (18) abolished WIN55,212-2-induced neurite retraction and converted CB 1 Rmediated neurite repulsion into chemoattraction without significantly affecting the rate of neurite extension (Fig. 3, A and B, and table S1 ). The agonist-induced coupling of CB 1 Rs to RhoA is 1 Rs are transported from the initial neurite segment through the neurite stem (arrowheads) to the growth cone, where they concentrate in filopodial tips (arrows) (movie S1). The structural classification of growth cones was based on whether microtubules in the central domain were bundled, spread, or looped (29) . (D and D′) AEA (100 nM) induces CB 1 R removal from filopodia. *P < 0.05, n = 13 to 15 filopodia per group from two independent experiments. Numbers indicate the periods of AEA exposure, in minutes. (E) CB 1 R activation induces Erk1/2 phosphorylation (pERK) in the central growth cone domain. (E′) Quantitative analysis of Erk1/2 phosphorylation 10 min after stimulation. o P < 0.01, *P < 0.05 (n = 10 growth cones per group). BDNF (100 ng/ml) was used as a positive control (14) . (F) AEA induces Erk1/2 phosphorylation in growth cones isolated from embryonic rat cortices. b-III tubulin served as a loading control. Error bars represent SEM. Scale bars, 3 mm in (A) to (C), 2.5 mm in (E), and 1 mm in (D).
25 MAY 2007 VOL 316 SCIENCE www.sciencemag.org consistent with the concept that Rho family GTPases control growth cone integrity by stimulating contraction of the actin cytoskeleton on the side facing the repellent gradient, thus leading to growth cone collapse (19, 22) . The conversion of growth cone steering decisions upon ROCK inhibition suggests that CB 1 Rs also activate the Cdc42 or Rac pathways, primary transducers of BDNF-induced chemoattraction (18, 20) , whose spatial and temporal antagonism with RhoA may be sufficient to switch (endo)cannabinoid-induced chemorepulsion to attractive turning (18) .
We addressed the in vivo significance of the above findings in adult mice (4.5 to 6 months of age) lacking endocannabinoid-mediated retrograde signaling at cortical inhibitory synapses (23) because of conditional CB 1 (24) . We identified perisomatic GABAergic terminals that would otherwise have expressed CB 1 Rs in the neocortex and hippocampus of CB 1 R f/f;Dlx5/6-Cre mice by their coexpression of the vesicular GABA (VGAT) and vesicular glutamate 3 (VGLUT3) transporters (25, 26) (Fig. 4C and fig. S6 ). Analysis of the distribution of VGAT + /VGLUT3 + boutons in layer 2/3 of the neocortex revealed a significant increase in the probability of pyramidal cells receiving VGAT + /VGLUT3 + inputs (Fig. 4, D to E′) , indicating impaired postsynaptic target selection of cortical interneurons lacking CB 1 R-mediated endocannabinoid signals. These changes occurred in the absence of altered interneuron migration or neurochemical specification ( fig. S7 ).
Our findings outline an essential developmental role for endocannabinoid signaling in growth cone steering decisions, identifying endocannabinoids as a class of signaling molecules that regulate axon guidance. This function is evident in diverse CB 1 R-expressing neuron populations as demonstrated in vitro by growth cone turning assays on CB 1 R-expressing GABAergic interneurons in rodents and Xenopus spinal cord neurons. Our evidence that CB 1 R-mediated endocannabinoid signals underpin growth cone steering by chemical and electrical extracellular directional cues, both of which are present in the embryonic CNS, suggests that endocannabinoid signals play an unexpectedly fundamental role in axonal pathfinding and neuritogenesis. The coincidence of intrinsic endocannabinoid synthesis in elongating long-range and GABAergic axons demonstrates that autocrine endocannabinoid signaling (11) contributes to the initial growth of axons, whereas target-derived endocannabinoid signals control axonal navigation and positioning. Our conclusion is also supported by neuroanatomical findings showing endocannabinoid synthetic enzymes in cortical neurons coincident with the enrichment of CB 1 Rs in neuronal growth cones during the critical period of postsynaptic target selection. Genetic evidence in CB 1 R f/f;Dlx5/6-Cre mice (24) reveals that interneuron-specific deletion of CB 1 R-mediated endocannabinoid signaling is sufficient to relieve the restriction of axonal elongation and branching (12) , synaptogenesis (27) , and target innervation mediated by endocannabinoid signals in neurochemically identified cortical interneurons. The present study also expands our understanding of how prenatal exposure to the CB 1 R agonist D 9 -tetrahydrocannabinol (THC), the major psychoactive constituent in cannabis, could affect CNS development and induce cognitive and behavioral deficits enduring into adolescence of THCexposed offspring (28) . Thus, our data, together with THC-induced impairment of synapse formation (27) , imply that maternal marijuana consumption may affect neurodevelopment through sustained CB 1 R activation and disrupt the proper positioning, postsynaptic target selectivity, and functional differentiation of developing axons. 
